Essex Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-19,135
| Closed | -$1.02M | – | 443 |
|
|
2020
Q4 | $1.02M | Sell |
19,135
-5,865
| -23% | -$314K | 0.13% | 224 |
|
|
2020
Q3 | $1.03M | Buy |
+25,000
| New | +$1.03M | 0.15% | 210 |
|
|
2019
Q1 | – | Sell |
-39,376
| Closed | -$637K | – | 480 |
|
|
2018
Q4 | $637K | Sell |
39,376
-656
| -2% | -$10.6K | 0.1% | 239 |
|
|
2018
Q3 | $831K | Buy |
+40,032
| New | +$831K | 0.1% | 253 |
|
|
2016
Q4 | – | Sell |
-16,647
| Closed | -$530K | – | 340 |
|
|
2016
Q3 | $530K | Hold |
16,647
| – | – | 0.09% | 244 |
|
|
2016
Q2 | $540K | Hold |
16,647
| – | – | 0.09% | 224 |
|
|
2016
Q1 | $465K | Hold |
16,647
| – | – | 0.08% | 238 |
|
|
2015
Q4 | $593K | Hold |
16,647
| – | – | 0.09% | 220 |
|
|
2015
Q3 | $551K | Hold |
16,647
| – | – | 0.09% | 218 |
|
|
2015
Q2 | $697K | Hold |
16,647
| – | – | 0.11% | 202 |
|
|
2015
Q1 | $543K | Hold |
16,647
| – | – | 0.08% | 227 |
|
|
2014
Q4 | $529K | Hold |
16,647
| – | – | 0.08% | 215 |
|
|
2014
Q3 | $412K | Hold |
16,647
| – | – | 0.06% | 244 |
|
|
2014
Q2 | $376K | Hold |
16,647
| – | – | 0.06% | 272 |
|
|
2014
Q1 | $405K | Hold |
16,647
| – | – | 0.06% | 266 |
|
|
2013
Q4 | $416K | Hold |
16,647
| – | – | 0.06% | 287 |
|
|
2013
Q3 | $457K | Hold |
16,647
| – | – | 0.07% | 264 |
|
|
2013
Q2 | $302K | Buy |
+16,647
| New | +$302K | 0.05% | 270 |
|